JPWO2022082059A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022082059A5 JPWO2022082059A5 JP2023523050A JP2023523050A JPWO2022082059A5 JP WO2022082059 A5 JPWO2022082059 A5 JP WO2022082059A5 JP 2023523050 A JP2023523050 A JP 2023523050A JP 2023523050 A JP2023523050 A JP 2023523050A JP WO2022082059 A5 JPWO2022082059 A5 JP WO2022082059A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- cells
- amino acid
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092736P | 2020-10-16 | 2020-10-16 | |
| US63/092,736 | 2020-10-16 | ||
| US202163151483P | 2021-02-19 | 2021-02-19 | |
| US63/151,483 | 2021-02-19 | ||
| PCT/US2021/055302 WO2022082059A1 (en) | 2020-10-16 | 2021-10-15 | Chimeric receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545517A JP2023545517A (ja) | 2023-10-30 |
| JPWO2022082059A5 true JPWO2022082059A5 (https=) | 2024-10-18 |
| JP2023545517A5 JP2023545517A5 (https=) | 2024-10-18 |
Family
ID=81209346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523050A Pending JP2023545517A (ja) | 2020-10-16 | 2021-10-15 | キメラ受容体およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4228682A4 (https=) |
| JP (1) | JP2023545517A (https=) |
| KR (1) | KR20230109138A (https=) |
| AU (1) | AU2021361993A1 (https=) |
| CA (1) | CA3195817A1 (https=) |
| IL (1) | IL302148A (https=) |
| TW (1) | TWI907544B (https=) |
| WO (1) | WO2022082059A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250006910A (ko) * | 2022-04-20 | 2025-01-13 | 센티 바이오사이언시스, 인코포레이티드 | 항원 결합 도메인 및 이의 사용 방법 |
| WO2025085867A1 (en) * | 2023-10-20 | 2025-04-24 | A2 Biotherapeutics, Inc. | Compositions and methods for treating blood cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6199054B2 (ja) * | 2013-03-19 | 2017-09-20 | 公益財団法人かずさＤｎａ研究所 | 抗イヌＩｇＥモノクローナル抗体並びに抗イヌＩｇＥモノクローナル抗体の重鎖可変領域及び軽鎖可変領域 |
| BR112016025450A2 (pt) * | 2014-05-02 | 2017-12-12 | Medimmune Ltd | moduladores de canais de íons e usos dos mesmos |
| WO2017173327A1 (en) * | 2016-03-31 | 2017-10-05 | The Schepens Eye Research Institute, Inc. | Endomucin inhibitor as an anti-angiogenic agent |
| US20200316120A1 (en) * | 2018-09-28 | 2020-10-08 | Immpact-Bio Ltd. | METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIES |
| EP3962527A4 (en) * | 2019-04-30 | 2023-11-01 | Senti Biosciences, Inc. | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF |
| CN115298209A (zh) * | 2020-02-20 | 2022-11-04 | 森迪生物科学公司 | 抑制性嵌合受体构造体 |
-
2021
- 2021-10-15 KR KR1020237016201A patent/KR20230109138A/ko active Pending
- 2021-10-15 AU AU2021361993A patent/AU2021361993A1/en active Pending
- 2021-10-15 WO PCT/US2021/055302 patent/WO2022082059A1/en not_active Ceased
- 2021-10-15 IL IL302148A patent/IL302148A/en unknown
- 2021-10-15 EP EP21881235.2A patent/EP4228682A4/en active Pending
- 2021-10-15 JP JP2023523050A patent/JP2023545517A/ja active Pending
- 2021-10-15 CA CA3195817A patent/CA3195817A1/en active Pending
- 2021-10-18 TW TW110138533A patent/TWI907544B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240342305A1 (en) | Antibody against glypican-3 and application thereof | |
| RU2748281C2 (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| JP6908722B2 (ja) | 抗ｐｄ−１抗体及びその使用 | |
| CN104822704B (zh) | 针对分化簇3(cd3)的人源化的抗体 | |
| US20050079170A1 (en) | Dimeric and multimeric antigen binding structure | |
| CA3101510A1 (en) | Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy | |
| EP4039705A1 (en) | Antibody targeting bcma, bispecific antibody, and use thereof | |
| KR20190034588A (ko) | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 | |
| IL268206B1 (en) | Bcma-targeting antibody and use thereof | |
| JP2018533371A5 (https=) | ||
| US20240002544A1 (en) | Cd28 bispecific antibodies for targeted t cell activation | |
| JP7646768B2 (ja) | 抗－ヒトプログラム細胞死リガンド－１（ｐｄ－ｌ１）の抗体及びその用途 | |
| JP2024504820A (ja) | 抗ｔｎｆｒ２ヒト化抗体及びその使用 | |
| CN116323667A (zh) | 结合PSMA和γ-δT细胞受体的抗体 | |
| CN113454111A (zh) | 抗体配制剂 | |
| JP2023530083A (ja) | Ｈｌａ－ｇ及び別の抗原に対して結合特異性を有する二重特異性免疫細胞エンゲージャー | |
| JPWO2019137541A5 (https=) | ||
| IL302148A (en) | Chimeric receptors and methods of use thereof | |
| EP4480966A1 (en) | Humanized anti-cd28 antibody and bispecific antibody thereof with anti-cd40 antibody | |
| CN116178545B (zh) | 一种抗人pd-l1人源化抗体或其抗原结合片段及其应用 | |
| WO2023125289A1 (zh) | 抗pd-1抗体及其用途 | |
| JP7725066B2 (ja) | ヒト化抗ｐｄ－ｌ１抗体 | |
| JPWO2022082059A5 (https=) | ||
| JPWO2022236142A5 (https=) | ||
| AU2023365454A1 (en) | Therapeutic agent for t cell malignancies |